Connection

Co-Authors

Back to Details
This is a "connection" page, showing publications co-authored by Bart Lambrecht and Bastiaan Maes.
Bart Lambrecht
Connection Strength
2.674
Bastiaan Maes
  1. Correction to: Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 06 22; 21(1):556.
    View in: PubMed
    Score: 0.888
  2. Treatment of severely ill COVID-19 patients with anti-interleukin drugs (COV-AID): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 03; 21(1):468.
    View in: PubMed
    Score: 0.885
  3. Case Report: Convalescent Plasma, a Targeted Therapy for Patients with CVID and Severe COVID-19. Front Immunol. 2020; 11:596761.
    View in: PubMed
    Score: 0.229
  4. Zilucoplan in patients with acute hypoxic respiratory failure due to COVID-19 (ZILU-COV): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Nov 19; 21(1):934.
    View in: PubMed
    Score: 0.229
  5. Correction to: Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 06 22; 21(1):554.
    View in: PubMed
    Score: 0.222
  6. Sargramostim to treat patients with acute hypoxic respiratory failure due to COVID-19 (SARPAC): A structured summary of a study protocol for a randomised controlled trial. Trials. 2020 Jun 05; 21(1):491.
    View in: PubMed
    Score: 0.221
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.